Product Images Venofer (iron Sucrose)

Table 2 displays the changes in Hemoglobin and Hematocrit parameters from baseline for the Venofer group and the Historical Control group at the end of treatment, 2-week follow-up, and 5-week follow-up. The efficacy of the treatment is not available due to incomplete information.*

This text provides information on the recommended population dose for various groups of patients with chronic kidney disease (CKD) undergoing hemodialysis, peritoneal dialysis, or not requiring dialysis. The recommended dosage ranges from 100mg to 400mg, administered intravenously through slow injection or infusion. The text also specifies different dosages for pediatric patients with CKD.*

This is a list of different packages of vials containing a medication of varying dosages (50mg, 100mg, and 200mg) with different quantities per package.*

Venofer is an injection medication containing Iron Sucrose. The package insert must be consulted for more information. The medication is distributed by HF Acquisition Co., LLC located in Mukilteo, WA. It is only for intravenous use and comes in a single-dose of 5 mL, containing 100 mg elemental Iron per 5 ml. Any unused portion should be discarded. The NDC number for the medication is 0517-2340-01.*

This is a pharmaceutical product label for Venofer which is an iron supplement for intravenous use only. Each 5ml vial contains 100mg elemental iron as iron sucrose injection with a pH of 10.5 to 11.1 and approximately 30% sucrose w/v. The product does not contain any preservatives and should be stored at 20°C to 25°C (68°F to 77°F). The label also includes the product Lot/Exp number and the manufacturer's name and address, American Regent, Inc.*